[1] Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008. 48: 169-176.
[2] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 肝脏, 2015, 20: 750-767.
[3] Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol, 2014, 109: 950-966, 967.
[4] Nin CT, Cheung WI, Ngan T, et al. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM). Clin Toxicol (Phila), 2011, 49: 34-39.
[5] Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci, 2015, 17: pii: E14.
[6] Padda MS, Sanchez M, Akhtar AJ, et al. Drug-induced cholestasis. Hepatology, 2011, 53: 1377-1387.
[7] 于乐成, 陈成伟. ACG 特异质性药物性肝损伤临床诊治指南解读. 肝脏, 2014: 570-574.
[8] Wikstrom SE, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG, 2013, 120: 717-723.
[9] Ozkan S, Ceylan Y, Ozkan OV, Yildirim S. Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy. World J Gastroenterol, 2015, 21: 7134-7141.
[10] Gabzdyl EM, Schlaeger JM. Intrahepatic cholestasis of pregnancy: a critical clinical review. J Perinat Neonatal Nurs, 2015, 29: 41-50.
[11] Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology, 2004, 40: 467-474.
[12] 江宇泳. 药物诱导的自身免疫性肝炎. 药物不良反应杂志, 2008, 10: 199-204.
[13] Buchel E, Van Steenbergen W, Nevens F, et al. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol, 2002, 97: 3160-3165.
[14] Burra P. Liver abnormalities and endocrine diseases. Best Pract Res Clin Gastroenterol, 2013, 27: 553-563.
[15] Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology, 2010, 51: 2193-2213.
[16] Erlinger S. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: good, but can do better. Clin Res Hepatol Gastroenterol, 2013, 37: 117-118.
[17] Roncaglia N, Locatelli A, Arreghini A, et al. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG, 2004, 111: 17-21. |
